Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Graeme Kaufman Insider Profile
4 Followers
Graeme Kaufman, Director at Paradigm Biopharmaceuticals Ltd., holds 1.89M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF). Most recently, Graeme Kaufman Sold $184,216 shares of Paradigm Biopharmaceuticals Ltd. on May 12, 2020 for an estimated value of 423.70K.
Graeme Kaufman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Graeme Kaufman's holdings
Insider Roles
Director
Roles that Graeme Kaufman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 12, 2020 - May 12, 2021
Return:-97.70%
The most profitable trade made by Graeme Kaufman
Graeme Kaufman's Trading History
List of latest transactions for each holding click on a transaction to see Graeme Kaufman's performance on stock
You May Also Like
Graeme Kaufman insider profile FAQ
What is the percentage of profitable transactions made by Graeme Kaufman?
The percentage of profitable transactions made by Graeme Kaufman is ―.
What is the average return per transaction made by Graeme Kaufman?
The average return per transaction made by Graeme Kaufman is ―.
What stocks does Graeme Kaufman hold?
Graeme Kaufman holds: PBIGF stocks.
What was Graeme Kaufman’s latest transaction?
Graeme Kaufman latest transaction was an Informative Sell of $423.70K.
What was Graeme Kaufman's most profitable transaction?
Graeme Kaufman’s most profitable transaction was an Informative Sell of PBIGF stock on May 12, 2020. The return on the trade was -97.70%.
What is Graeme Kaufman's role in Paradigm Biopharmaceuticals Ltd.?
Graeme Kaufman's role in Paradigm Biopharmaceuticals Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.